C-X-C motif chemokine ligand 12 (CXCL12) (CXCL12)

CXCL12 is a pleiotropic, primarily homeostatic CXC chemokine that binds CXCR4 and ACKR3 to regulate leukocyte trafficking, stem/progenitor cell retention in bone marrow, angiogenesis, and embryogenesis; it exists as multiple human splice variants and is tightly regulated by expression, glycosaminoglycan binding, oligomerization, and post-translational modifications. In pathology, particularly cancer, the CXCL12/CXCR4/CXCR7 axis activates diverse signaling cascades (MAPK, PI3K, calcium/β-arrestin) to promote proliferation, survival, metastasis, angiogenesis, and therapy resistance, making the axis a therapeutic target for antagonists and ligand-directed inhibitors.

Other names

Stromal cell-derived factor 1 (SDF-1)CXCL12SDF1-α/β and other splice variants (human CXCL12 has multiple splice variants)

CXCR4 antagonism blocks CXCL12-induced Gαi signaling, calcium mobilization, MAPK/PI3K activation, chemotaxis, and survival signals in tumor and immune cells. Ligand sequestration or neutralization (small molecules binding CXCL12 to prevent receptor engagement). Modulation of ACKR3 (CXCR7) scavenging/biased signaling to alter CXCL12 availability and downstream signaling profiles.